Ohio State Medical Oncology
@OhioStateMedOnc
Followers
533
Following
1K
Statuses
836
The OSU Division of Medical Oncology: providing cutting-edge compassionate care through team science to those diagnosed with solid tumor malignancies
Columbus, OH, USA
Joined January 2023
🩺Meet one of our #lungcancer oncologists, Dr. David Carbone, whose research focuses on proteomic and expression array signature development, genetics, immunotherapy & tumor-associated immunosuppression mechanisms in lung cancer.
0
0
6
📝New publication from our #breastcancer team & colleagues: Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple-negative breast cancer @SpringerNature
0
1
3
Clinical trials are so important! Read about how clinical trials drive medical developments below & find a @OSUCCC_James clinical trial here:
Clinical trials are the backbone of medical breakthroughs, driving innovation and shaping the future of health care. Hear from #OSUCOM's @DeanBradford, Dr. Ann Scheck McAlearney, @Gumina_Lab and Dr. Julie Johnson about the importance of these studies.
0
0
4
On #WorldCancerDay, we are grateful for those working to save lives through science, education, clinical care, and research! @OSUCCC_James @OhioStateMedOnc
0
2
3
🩺On National Women Physicians Day, we recognize the excellent care our @OSUCCC_James #medicaloncology women physicians provide to their patients, their important contributions to science, and their mentoring and leadership!
0
4
12
RT @ChristianRolfo: OSU SABCS meeting - 200 participants in attendance. Great turn out and awesome presentations by our amazing Breast Canc…
0
6
0
RT @OhioStatePIIO: 📢 Join us for the Third Annual Symposium on the Biological Basis of #Sex_Differences in #Cancer! 🗓 Feb. 28, 2025 | ⏰ 9…
0
7
0
RT @OSUCCC_James: Even a drink or two a day could increase your risk of cancer, according to a new report.
0
3
0
🚨We are hiring Medical Oncologists at @OhioStateMedOnc ! Check the QR code below for the available positions! 3 pathways: - Physician Scientist - Clinical Scholar - Clinical Excellence Send your applications @OSUCCC_James @OhioStateMed
0
4
6
📝New publication from @shafiarahman_ in #ASCODailyNews: Adjuvant Therapy Postresection in Pancreatic Ductal Adenocarcinoma: What Is the Best Option After Neoadjuvant FOLFIRINOX–Associated Toxicity? @ASCO
0
0
3
👏Congrats to Dr. Claire Verschraegen, who was selected as the #SWOG representative/member of the NCTN Core Correlative Sciences Committee starting this month. She will play a key role in guiding the strategic direction of clinical trials and advancing cancer research.
1
3
21
📅Join us for the San Antonio Breast Cancer Symposium Review on 2/1/2025. Details below!
0
0
0
👏Congratulations to @JKaufmanLungNED on this K08!
"Congrats to @OSUCCC_James, @OhioStateMedOnc, #PIIO researcher, Dr. @JKaufmanLungNED, on receiving an NCI K08 grant to support research on overcoming #immunotherapy resistance in #NSCLC.👏🔬 Read more:
0
1
8
Recent #microbiome research from @dspakowicz & colleagues
🚨New publication from a research team that includes @OhioStateMedOnc, #PIIO researcher Dr. @dspakowicz on #GutMicrobiome, #immune shifts, & #MentalHealth during an immersive psychosocial intervention. Findings reveal links between Prevotella-dominant #microbiome & #depression resilience. 🧠🦠 Read more:
0
0
1
🏥Meet the doctor: Amir Mortazavi, MD, focuses on GU cancers, including bladder, prostate, testicular & kidney cancers, with a research focus on epigenetic modifications and experimental therapeutics for GU cancers.
0
1
12
RT @herbloong: 📢 @isliquidbiopsy conducting global survey 🌎 on #attitudes, #practices & #barriers of #liquidbiopsies for practicing #oncolo…
0
7
0
RT @AshishManne: Postoperative serum MUC5AC can predict recurrence patterns and outcomes in pancreatic cancer. Our abstract at GIASCO #GI…
0
1
0
🔎Search for a clinical trial at @OSUCCC_James:
Learn how cancer clinical trials connect tomorrow's treatments with today's patients. Click for details, and to register for this free 2/28 webinar from the @NCCN.
0
0
1
Dr. @AshishManne shows that "targeted methylation signatures, supported by robust preclinical or translational evidence of their impact on treatment resistance, can be clinically valuable for informing treatment selection and prognosis" in PDA. #GI25
0
0
5
New research from Dr. Alayna Tackett & colleagues.
Dr. Tackett and colleagues found nicotine gums may offer a more pleasant sensory experience than pouches for young adults who use e-cigarettes, with variation across brand/flavor variants. @NTR_Journal @OSUWexMed @OSUCCC_James
0
0
0